Lynx Dx
Shannon Kelley is an experienced professional in the field of molecular technology, currently serving as General Molecular Supervisor and previously as Molecular Laboratory Technician II at Lynx Dx since August 2021. Prior to this role, Shannon held the position of Molecular Technologist II- Extraction at Progenity, Inc. from April 2018 to September 2021. Educationally, Shannon holds a Master of Arts in Science Teacher Education from The University of Toledo, completed in December 2014, and a Bachelor of Science in Marine Biology and Biological Oceanography from Texas A&M University Galveston Campus, earned in December 2007.
This person is not in any teams
Lynx Dx
MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.